{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-089981","form_type":"8-K","ticker":null,"cik":"0001213660","company_name":"BIMI Holdings Inc.","filed_at":"2023-11-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.445586+00:00","generated_at":"2026-06-07T21:20:32.861836+00:00","sec_items":["3.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"BIMI receives Nasdaq delisting warning for failure to file Q3 10-Q; prior delinquency resolved","bullets":["On Nov 21, 2023, Nasdaq notified BIMI of non-compliance with Listing Rule 5250(c)(1) due to untimely Q3 10-Q filing.","Prior delinquency (Q2 10-Q) resolved with filing on Nov 22, 2023; deadline extension expires Feb 20, 2024.","Company must submit updated plan to regain compliance; no immediate effect on listing of shares."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-089981","json":"https://secwatch.observer/filing/0001213900-23-089981.json","markdown":"https://secwatch.observer/filing/0001213900-23-089981.md","text":"https://secwatch.observer/filing/0001213900-23-089981.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1213660/000121390023089981/0001213900-23-089981-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1213660/000121390023089981/ea189027-8k_bimiinter.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T21:20:32.861836+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"49d4bb2a3037790d1aa902d3166950c7612f52b3","claim":"BIMI Holdings Inc. received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).","evidence_excerpt":"November 21, 2023, BIMI International Medical Inc. (the “Company”) received a notification letter (the “Nasdaq Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) stating that, because the Company has not yet filed its Quarterly Report on Form 10-Q for the period ended September 30, 2023 (the “Third Quarter Form 10-Q”), the Company is no longer in compliance with Nasdaq Listing Rule 5250(c)(1). Nasdaq Listing Rule 5250(c)(1) requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission. The Nasdaq Letter also stated that Nasdaq ha","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1213660/000121390023089981/0001213900-23-089981-index.htm","confidence":0.98,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"noncompliance notice"},{"label":"Deficiency","value":"late filing"},{"label":"Rules","value":"5250(c)(1)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}